Loading
Alignment Healthcare, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 02 Jun 2026.
Alignment Healthcare, Inc.: what insiders have been doing
Every trade that managers of Alignment Healthcare, Inc. disclose to SEC (Form 4) is tracked on this page. The company sits in the Healthcare & Pharma sector. In the past year (18 October 2025 to 18 October 2026), 108 filings came from 28 insiders.
Both sides are active: 1 purchase worth €170k and 69 sales worth €253.1M, from 1 insider and 10 insiders respectively. The totals exclude 8 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Biggest ticket of the year: €175.9M, sold by General Atlantic (ALN HLTH), L.P. and made public on 12 December 2025. Those buying include 1 chief executive.
The most recent open-market purchase was published on 2 June 2026, 138 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
For context, the typical company on the same exchange (median of 5,458 companies) published 22 filings over the same period, against 108 filings here. The full history, which starts in 2021, counts 3 purchases against 282 sales. For the fiscal year to 31 December 2025, the annual 10-K puts revenue at 3.95 bn USD and net income at -724,000 USD.
Other companies in the same sector with recent insider buying flagged by our signals: Anixa Biosciences Inc and Vivos Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
438
Thresholds
n/a
Buy Volume
€1M
3 ops. · all time
Sell Volume
€1B
282 ops. · all time
Who traded when
BuySaleJohn E. Kao37 sales
Dawn Christine Maroney28 sales
Hyong Kim14 sales
Joseph S. Konowiecki12 sales
Joyce Christopher J11 sales
Scavo Robert L.9 sales
+8 other insiders
Since the insiders bought
- -41.9%Entry US$14.25 · Close 16 Oct 2026 US$8.28
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Alignment Healthcare, Inc. Strong Buy (bullish), based on 13 analysts. Average price target: US$22.23.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 18,101 of 24,148 companies
34.7
score / 100
Value36
Quality34
FCF yld6.9%
Earn yld-0.0%
EV/EBITDA43.6x
ROE20%
Gross mgn12%
Net mgn-0.0%
Debt/EBITDA7.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$7.93
Analyst consensus
13 analystsStrong buy
US$13.00Target US$22.23(+180%)US$28.00
Income statement
RevenueUS$3.9B
Gross profitUS$488.6M12% margin
EBITDAUS$45.3M1% margin
Net income-US$724k0.9% margin
Valuation
PER (trailing)44.1x
PER (forward)10.5x
P/Book6.2x
Beta1.11
Balance sheet & cash
Market capUS$1.6B
Total debtUS$329.6M
Free Cash FlowUS$113.1M
Debt / Equity125%
Profitability & ownership
ROE20.0%
ROA3.1%
% insiders2.6%
% institutions116.0%
Last declaration on 7 October 2026
Declarations438 total
36,000 shares@ US$8.48Common StockSEC144:0001628280-26-065053
23,511 shares@ US$8.610.012% mcap100.0% of flowCommon StockSEC:0001628280-26-062740:0
26,000 shares@ US$8.710.0079% mcap100.0% of flowCommon StockSEC144:0001628280-26-062327
27,400 shares@ US$13.000.021% mcap4.8% of flowCommon StockSEC:0001628280-26-062329:0
385,270 shares@ US$12.680.29% mcap65.4% of flowCommon StockSEC:0001628280-26-061620:1
122,707 shares@ US$12.680.093% mcap71.6% of flowCommon StockSEC:0001628280-26-061621:0
172,600 shares@ US$12.95740.13% mcap29.9% of flowCommon StockSEC:0001628280-26-061620:0
500,000 shares@ US$13.030.37% mcap33.8% of flowCommonSEC144:0001950047-26-009291
130,000 shares@ US$13.060.061% mcap100.0% of flowCommon StockSEC144:0001628280-26-061187
5,000 shares@ US$14.000.0041% mcap0.2% of flowCommon StockSEC:0001628280-26-057635:0
5,000 shares@ US$13.460.0039% mcap1.7% of flowCommonSEC144:0001950047-26-008148
298,000 shares@ US$13.88180.24% mcap3.9% of flowCommon StockSEC:0001628280-26-055418:0
152,068 shares@ US$9.060.080% mcap3.8% of flowCommon StockSEC:0001628280-26-048498:0
177,068 shares@ US$20.82810.22% mcap10.1% of flowCommon StockSEC:0001628280-26-048498:1
177,068 shares@ US$21.200.22% mcap98.3% of flowCommonSEC144:0001950047-26-007102
279,644 shares@ US$19.81220.32% mcap5.2% of flowCommon StockSEC:0001628280-26-048170:0
18,356 shares@ US$20.64710.022% mcap0.4% of flowCommon StockSEC:0001628280-26-048170:1
596,000 shares@ US$21.030.73% mcap66.2% of flowCommonSEC144:0001950047-26-007006
87,719 sharesCommon StockSEC:0001628280-26-046944:0
25,000 shares@ US$24.0053.8% of flowCommonSEC144:0001628280-26-046374
25,000 sharesCommon StockSEC:0001628280-26-046575:0
25,000 shares@ US$23.00100.0% of flowCommonSEC144:0001628280-26-045659
25,000 sharesCommon StockSEC:0001628280-26-045734:0
25 of 438 declarations
About Alignment Healthcare, Inc.
Alignment Healthcare, Inc. is a U.S.-based healthcare services company listed on the NASDAQ under the ticker ALHC, and its operating footprint is in the United States. The company was founded in 2013 with the stated mission of improving healthcare for seniors by addressing the fragmentation and complexity of the U.S. care system. Its headquarters are in Orange, California, in the Los Angeles area. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1832466/000162828026027060/alhc-annualreportfy2025.pdf?utm_source=openai))
At the center of the business is a next-generation, consumer-centric and clinically focused platform built primarily for Medicare beneficiaries, especially those enrolled in Medicare Advantage plans. Alignment Healthcare combines insurance, care coordination, and clinical support into an integrated model designed to simplify the senior healthcare journey. Management emphasizes the use of data and technology to improve access to care, close care gaps, and reduce avoidable hospital utilization, which is a key part of the company’s value proposition. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1832466/000162828026027060/alhc-annualreportfy2025.pdf?utm_source=openai))
Read moreShow less
From a competitive standpoint, Alignment Healthcare is a specialized Medicare Advantage player competing against both large diversified managed-care insurers and other focused senior-health platforms. Its differentiation lies in its tightly integrated care model, local provider coordination, and member experience. In its 2025 annual report, the company disclosed approximately 275,300 health plan members at year-end 2025 and operations across 45 markets in 5 states, highlighting strong growth but also a still-concentrated geographic base. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1832466/000162828026027060/alhc-annualreportfy2025.pdf?utm_source=openai))
The company’s key offerings include HMO and PPO Medicare Advantage plans marketed under the Alignment Health Plan brand. Beyond the insurance wrapper, the product proposition is built around easier access to care, better physician coordination, and support services tailored to seniors across home, digital, and community settings. For investors, the main strategic questions remain execution on membership growth, medical cost control, and margin expansion within a highly regulated U.S. Medicare environment. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1832466/000162828026027060/alhc-annualreportfy2025.pdf?utm_source=openai))
Recent developments point to solid operating momentum. Alignment Healthcare reported full-year 2025 results in early 2026 showing continued membership and revenue growth, and it followed with first-quarter 2026 results at the end of April 2026 that management described as strong, with disciplined growth and margin expansion. The company also updated or raised parts of its 2026 outlook in recent communications, suggesting improved confidence in the operating trajectory. As a NASDAQ-listed U.S. healthcare company, it is also worth monitoring SEC Form 4 insider transactions, which can provide useful context but should not be interpreted in isolation. ([globenewswire.com](https://www.globenewswire.com/news-release/2026/02/26/3246044/0/en/alignment-healthcare-reports-fourth-quarter-and-full-year-2025-results-beats-high-end-of-guidance-across-all-key-metrics.html?utm_source=openai))
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
